May 20, 2020 / 8:26 PM / 15 days ago

BRIEF-Cumberland Posts Q1 Adjusted EPS Of $0.01

May 20 (Reuters) - Cumberland Pharmaceuticals Inc:

* CUMBERLAND PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS & COMPANY UPDATE

* Q1 REVENUE $8.3 MILLION

* Q1 LOSS PER SHARE $0.07 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below